SCHEDULE 13D/A Filed 2026-10-16 Event 2026-10-14 SEC 0000921895-26-002806 →

BIOTECHNOLOGY VALUE FUND L P → Olema Pharmaceuticals, Inc. OLMA

Stake: — Shares: 5,946,981 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

4 transactions

2 buys · 2 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

44 filings by this filer

43 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 10.19

14,696,219 shares short · -8.5% vs prior

Institutional Consensus · 2026-06-30

Held by elite portfolio managers

2 holders · $8.06M

Duquesne Family OfficePoint72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-24	Harmon Cyrus	director	Sale	12,500	$11.71	$146K
2026-07-23	Harmon Cyrus	director	Sale	12,500	$11.58	$145K
2026-04-28	Raman Prakash	director	Award	2,911	$14.59	$42K
2026-04-28	Raman Prakash	director	Award	24,150	$14.59	$352K

Other Filings by BIOTECHNOLOGY VALUE FUND L P

Filed	Form	Issuer	Stake	Shares
2026-09-21	SCHEDULE 13G	Tyra Biosciences, Inc.	—	—	view →
2026-09-18	SCHEDULE 13G	Alector, Inc.	—	—	view →
2026-08-04	SCHEDULE 13D	Entera Bio Ltd.	9.99%	9,171,741	view →
2026-07-20	SCHEDULE 13G	Research Alliance Corp IV	—	—	view →
2026-07-16	SCHEDULE 13D/A	XOMA Royalty Corp	—	0	view →
2026-07-10	SCHEDULE 13G	Pyxis Oncology, Inc. PYXS	—	—	view →
2026-06-29	SCHEDULE 13D/A	MoonLake Immunotherapeutics MLTX	19.70%	8,302,735	view →
2026-06-26	SCHEDULE 13D/A	Kymera Therapeutics, Inc. KYMR	6.30%	2,712,852	view →
2026-06-04	SCHEDULE 13G	Q32 Bio Inc. QTTB	—	—	view →
2026-05-29	SCHEDULE 13G	Research Alliance Corp III RACC	—	—	view →
2026-05-27	SCHEDULE 13G	OnKure Therapeutics, Inc. OKUR	—	—	view →
2026-05-18	SCHEDULE 13D/A	XOMA Royalty Corp XOMAP	—	3,635,758	view →
2026-04-02	SCHEDULE 13D/A	MoonLake Immunotherapeutics MLTX	22.30%	8,302,735	view →
2025-11-24	SCHEDULE	Repare Therapeutics Inc.	24.00%	10,333,600	view →
2025-05-20	SCHEDULE	XOMA Royalty Corp XOMAP	21.60%	2,590,303	view →
2025-01-28	SCHEDULE	XOMA Royalty Corp XOMAP	25.30%	2,983,026	view →
2024-10-08	SC	MoonLake Immunotherapeutics MLTX	—	—	view →
2024-07-19	SC	Inventiva S.A. IVEVF	—	—	view →
2024-01-29	SC	Rain Oncology Inc.	—	—	view →
2024-01-09	SC	Kymera Therapeutics, Inc. KYMR	—	—	view →

Showing 20 of 43

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →